On October the 12th Prof. Mario A. Monteiro will give a lecture on Chemforum.

Mario Monteiro was born in Lisbon, but at the age of 2 years old moved to Serra da Estrela with his parents where he would do his early schooling. At the age of 14 he moved to Canada where he finished high school and University with a PhD at York University under the supervision of Professor Gerald Aspinall in 1996.

Following his doctorate, Prof. Monteiro joined the research group of Dr. Malcolm Perry at the National Research Council Canada with funding from the Canadian Bacterial Diseases Network. In 2001, Prof. Monteiro moved to the US to work at Wyeth (now Pfizer) as a Senior Scientist in the Carbohydrate division. Prof. Monteiro returned to Canada in 2004 to take up a faculty position in the Department of Chemistry at the University of Guelph. Mario Monteiro is now a Full Professor in the Department of Chemistry at the University of Guelph.

The current research interests of Prof. Monteiro are the discovery of carbohydrate-based vaccines against human gastric-pathogens. Most notably, so far he has created and licensed two key vaccines: one against traveller’s diarrhea (anti-Campylobacter jejuni) that is now in phase 1 human trials in the US; and another against Clostridium difficile that is now in pre-clinical trials at a US-based biotech company. His new campaign focuses on the development of vaccines to combat gastric infections associated with diarrhea in autistic children.

In 2014, he was considered one of the most influential people in the world of vaccines and in 2015 he was awarded the Professional award from the Luso-Canadian Federation.